Nuveen Asset Management, LLC Burning Rock Biotech LTD Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$6.7 - $10.23 $28,140 - $42,966	4,200 Added 8.79%	52,000 $483,000
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $250,838 - $455,924	-26,600 Reduced 35.75%	47,800 $456,000
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $86,850 - $139,600	5,000 Added 7.2%	74,400 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $1.81 Million - $2.6 Million	69,400 New	69,400 $2.05 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.